PRA Health Sciences Pioneers Connecting Clinical Trial Patients with Their Real-world Data with Synoma

RALEIGH, N.C., May 13 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, [...]